HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[3H]linopirdine (DuP 996) labels a novel binding site in rat brain involved in the enhancement of stimulus-induced neurotransmitter release: autoradiographic localization studies.

Abstract
A novel high-affinity binding site for linopirdine (DuP 996; 3,3-bis(4-pyrindinylmethyl)-1-phenylindolin-2-one), a cognitive enhancer which improves learning and memory in rodents and primates, has recently been identified in rat brain homogenates. [3H]Linopirdine binding sites were localized in rat brain using in vitro labeling, light microscopic autoradiography. Highest densities of binding sites were present in the hippocampus (CA1 to CA3 pyramidal cell layers and the granule cells of the dentate gyrus), the cerebral cortex (lamina IV), the dorsal raphe nucleus and the interpeduncular nucleus. Moderate densities were present in the olfactory bulb, olfactory tubercle, amygdala, subiculum and medial habenular nucleus. Lower levels of binding were present in the caudate/putamen, thalamus and hypothalamus. The localization of [3H]linopirdine binding sites in brain areas implicated in cognitive processes and affected in Alzheimer's disease suggest that ligands for this binding site may have therapeutic potential for the treatment of cognitive deficits seen in dementia.
AuthorsE B De Souza, B L Rule, S W Tam
JournalBrain research (Brain Res) Vol. 582 Issue 2 Pg. 335-41 (Jun 12 1992) ISSN: 0006-8993 [Print] Netherlands
PMID1356584 (Publication Type: Journal Article)
Chemical References
  • Indoles
  • Neurotransmitter Agents
  • Pyridines
  • Tritium
  • linopirdine
Topics
  • Animals
  • Autoradiography
  • Brain (metabolism)
  • Indoles (metabolism)
  • Male
  • Neurotransmitter Agents (metabolism)
  • Pyridines (metabolism)
  • Radioligand Assay
  • Rats
  • Rats, Sprague-Dawley
  • Tritium

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: